bpc 157 natty or not BPC-157: Experimental Peptide Creates Risk for Athletes BPC-157 Research Peptide | Lyophilized

Drug Delivery and Translational Research

PMID: 36170435

This applies to all conditions listed with diabetes in the Index (CKD, neuropathy, retinopathy, etc.)

The relationship is that TB-500 is a truncated active fragment of Thymosin Beta-4 and identified through systematic deletion analysis as the minimal sequence retaining the full biological activity of the intact protein in wound healing, cell migration, and angiogenesis assays

The peptide upregulates expression of various angiogenic factors and promotes formation of new capillary networks, which are essential for adequate tissue perfusion and nutrient delivery during healing processes